Despite some employers' push to curb its use among applicants, local experts say AI tools have legitimate uses for jobseekers ...
Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could not have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback